538 related articles for article (PubMed ID: 16888758)
1. Mass spectrometry in sports drug testing: Structure characterization and analytical assays.
Thevis M; Schänzer W
Mass Spectrom Rev; 2007; 26(1):79-107. PubMed ID: 16888758
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometric determination of insulins and their degradation products in sports drug testing.
Thevis M; Thomas A; Schänzer W
Mass Spectrom Rev; 2008; 27(1):35-50. PubMed ID: 18000882
[TBL] [Abstract][Full Text] [Related]
3. Sports drug testing--an analyst's perspective.
Trout GJ; Kazlauskas R
Chem Soc Rev; 2004 Jan; 33(1):1-13. PubMed ID: 14737504
[TBL] [Abstract][Full Text] [Related]
4. Preventive doping control screening analysis of prohibited substances in human urine using rapid-resolution liquid chromatography/high-resolution time-of-flight mass spectrometry.
Vonaparti A; Lyris E; Angelis YS; Panderi I; Koupparis M; Tsantili-Kakoulidou A; Peters RJ; Nielen MW; Georgakopoulos C
Rapid Commun Mass Spectrom; 2010 Jun; 24(11):1595-609. PubMed ID: 20486255
[TBL] [Abstract][Full Text] [Related]
5. Implementation of gas chromatography combined with simultaneously selected ion monitoring and full scan mass spectrometry in doping analysis.
Van Thuyne W; Van Eenoo P; Delbeke FT
J Chromatogr A; 2008 Nov; 1210(2):193-202. PubMed ID: 18849031
[TBL] [Abstract][Full Text] [Related]
6. Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification.
Nielen MW; Bovee TF; van Engelen MC; Rutgers P; Hamers AR; van Rhijn JH; Hoogenboom LR
Anal Chem; 2006 Jan; 78(2):424-31. PubMed ID: 16408923
[TBL] [Abstract][Full Text] [Related]
7. New drugs and methods of doping and manipulation.
Thevis M; Kohler M; Schänzer W
Drug Discov Today; 2008 Jan; 13(1-2):59-66. PubMed ID: 18190865
[TBL] [Abstract][Full Text] [Related]
8. Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays.
Houtman CJ; Sterk SS; van de Heijning MP; Brouwer A; Stephany RW; van der Burg B; Sonneveld E
Anal Chim Acta; 2009 Apr; 637(1-2):247-58. PubMed ID: 19286037
[TBL] [Abstract][Full Text] [Related]
9. A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography/time-of-flight mass spectrometry.
Kolmonen M; Leinonen A; Pelander A; Ojanperä I
Anal Chim Acta; 2007 Feb; 585(1):94-102. PubMed ID: 17386652
[TBL] [Abstract][Full Text] [Related]
10. Mass spectrometric identification of peptide hormones in doping-control analysis.
Thevis M; Schänzer W
Analyst; 2007 Apr; 132(4):287-91. PubMed ID: 17554406
[TBL] [Abstract][Full Text] [Related]
11. Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids.
Georgakopoulos CG; Vonaparti A; Stamou M; Kiousi P; Lyris E; Angelis YS; Tsoupras G; Wuest B; Nielen MW; Panderi I; Koupparis M
Rapid Commun Mass Spectrom; 2007; 21(15):2439-46. PubMed ID: 17610244
[TBL] [Abstract][Full Text] [Related]
12. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry I. Screening analysis.
Badoud F; Grata E; Perrenoud L; Avois L; Saugy M; Rudaz S; Veuthey JL
J Chromatogr A; 2009 May; 1216(20):4423-33. PubMed ID: 19342059
[TBL] [Abstract][Full Text] [Related]
13. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry. II: Confirmatory analysis.
Badoud F; Grata E; Perrenoud L; Saugy M; Rudaz S; Veuthey JL
J Chromatogr A; 2010 Jun; 1217(25):4109-19. PubMed ID: 19939397
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometric identification and characterization of a new long-term metabolite of metandienone in human urine.
Schänzer W; Geyer H; Fusshöller G; Halatcheva N; Kohler M; Parr MK; Guddat S; Thomas A; Thevis M
Rapid Commun Mass Spectrom; 2006; 20(15):2252-8. PubMed ID: 16804957
[TBL] [Abstract][Full Text] [Related]
15. Rapid screening of doping agents in human urine by vacuum MALDI-linear ion trap mass spectrometry.
Kosanam H; Prakash PK; Yates CR; Miller DD; Ramagiri S
Anal Chem; 2007 Aug; 79(15):6020-6. PubMed ID: 17602668
[TBL] [Abstract][Full Text] [Related]
16. Doping control analysis of tricyclic tetrahydroquinoline-derived selective androgen receptor modulators using liquid chromatography/electrospray ionization tandem mass spectrometry.
Thevis M; Kohler M; Thomas A; Schlörer N; Schänzer W
Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2471-8. PubMed ID: 18634123
[TBL] [Abstract][Full Text] [Related]
17. Determination of the prevalence of anabolic steroids, stimulants, and selected drugs subject to doping controls among elite sport students using analytical chemistry.
Thevis M; Sauer M; Geyer H; Sigmund G; Mareck U; Schänzer W
J Sports Sci; 2008 Aug; 26(10):1059-65. PubMed ID: 18608840
[TBL] [Abstract][Full Text] [Related]
18. Detection of anabolic steroid abuse using a yeast transactivation system.
Zierau O; Lehmann S; Vollmer G; Schänzer W; Diel P
Steroids; 2008 Oct; 73(11):1143-7. PubMed ID: 18550137
[TBL] [Abstract][Full Text] [Related]
19. Expanding sports drug testing assays: mass spectrometric characterization of the selective androgen receptor modulator drug candidates RAD140 and ACP-105.
Thevis M; Piper T; Beuck S; Geyer H; Schänzer W
Rapid Commun Mass Spectrom; 2013 Jun; 27(11):1173-82. PubMed ID: 23650030
[TBL] [Abstract][Full Text] [Related]
20. Screening for anabolic steroids in doping analysis by liquid chromatography/electrospray ion trap mass spectrometry.
Deventer K; Eenoo PV; Delbeke FT
Biomed Chromatogr; 2006 May; 20(5):429-33. PubMed ID: 16177960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
